The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis

BACKGROUND/AIM: Patients with HBV-related decompensated cirrhosis (HBV-DeCi) should be treated with potent nucleos(t)ide analogues (NA)[entecavir (ETV) or tenofovir (TDF)]. The aim was the evaluation of safety and efficacy in terms of changes in liver disease course in HBV-DeCi patients treated with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Gastroenterol
Main Authors: Cholongitas, Evangelos, Papatheodoridis, George V., Goulis, John, Vlachogiannakos, John, Karatapanis, Stylianos, Ketikoglou, John, Vasiliadis, Themistoklis, Kontos, George, Karlaftis, Anastasios, Akriviadis, Evangelos
Formato: Artigo
Idioma:Inglês
Publicado em: Hellenic Society of Gastroenterology 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289983/
https://ncbi.nlm.nih.gov/pubmed/25608681
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados